Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
09/2014
09/16/2014US8835689 Substituted 4-aminocyclohexane derivatives
09/16/2014US8835652 Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it
09/16/2014US8835646 Organic compounds
09/16/2014US8835611 Calicheamicin derivative-carrier conjugates
09/16/2014US8835512 Therapeutic application of cembranoids against HIV virus replication, HIV-associated neurocognitive disorders and HIV virus-induced inflammation
09/16/2014US8835497 Compositions for improved oxidative status in companion animals
09/16/2014US8835488 Opioid receptor ligands and methods of using and making same
09/16/2014US8835450 Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancer
09/16/2014US8835438 Method of treating memory/learning dysfunctions caused by schizophrenia with lurasidone
09/16/2014US8835430 2,4-pyrimidinediamine compounds and their uses
09/16/2014US8835420 Azaindole derivatives
09/16/2014US8835380 Therapeutic conjugates
09/16/2014US8834943 Compositions containing amines and use thereof
09/16/2014US8834940 Compositions and method for hair loss prevention
09/16/2014US8834925 Tamper resistant dosage forms
09/16/2014US8834900 Combination motif immune stimulatory oligonucleotides with improved activity
09/16/2014US8834898 Cholera toxin chimera and its use as a staph vaccine
09/16/2014US8834891 Immunogenic compositions comprising Lawsonia intracellularis
09/16/2014US8834886 Camptothecin-binding moiety conjugates
09/16/2014US8834869 Pharmacological vitreolysis
09/16/2014US8834858 Treatment for dyslipidemia
09/16/2014US8834853 Coated dehydrated microorganisms with enhanced stability and viability
09/16/2014US8834849 Medicinal aerosols and methods of delivery thereof
09/16/2014US8834544 Photodynamic therapy for tumors with localized delivery
09/16/2014US8834445 Methods of treating or preventing peritonitis with oxidative reductive potential water solution
09/16/2014CA2677842C Pharmaceutical composition comprising microparticle oily suspension
09/16/2014CA2570887C Tumor treatment
09/16/2014CA2408791C Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
09/12/2014WO2014138364A2 Methods of treating and preventing cancer drug resistance
09/12/2014WO2014138018A1 Preservative free bimatoprost and timolol solutions
09/12/2014WO2014135529A1 Mixture of fatty acids for use in the treatment of inflammatory pathologies
09/12/2014WO2014135460A1 Use of (rs)-s-cyclopropyl-s-(4-{[4-{[(1r,2r)-2-hydroxy-1-methylpropyl]- oxy}-5-(trifluoromethyl)pyrimidin-2-yl]amino}phenyl)sulfoximide for treatment of specific tumours
09/12/2014WO2014135123A1 17α-ethynyl-androst-5-ene-3β,7β,17β-triol ophthalmic preparation
09/11/2014US20140257516 Connective-Tissue-Based or Dermal-Tissue-Based Grafts/Implants
09/11/2014US20140257238 Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device
09/11/2014US20140256821 Intrannasal administration of ketamine to treat depression
09/11/2014US20140256816 Adamantyl Derivatives as Therapeutic Agents
09/11/2014US20140256789 Composition and methods for modulating cell proliferation and cell death
09/11/2014US20140256786 Compositions and methods for treatment of mitochondrial diseases
09/11/2014US20140256778 High affinity beta lactamase inhibitors
09/11/2014US20140256760 Reduction or prevention of alcohol reaction with dietary supplements
09/11/2014US20140256748 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same
09/11/2014US20140256746 Methods for Treating Osteoarthritis
09/11/2014US20140256743 Cathepsin cysteine protease inhibitors
09/11/2014US20140256733 Mixed lineage kinase inhibitors and method of treatments
09/11/2014US20140256717 Macrocyclic compounds as protein kinase inhibitors
09/11/2014US20140256706 Bet bromodomain inhibitors and therapeutic methods using the same
09/11/2014US20140256693 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
09/11/2014US20140256682 Co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis
09/11/2014US20140256680 Combination therapy of hsp90 inhibitors with braf inhibitors
09/11/2014US20140256674 Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
09/11/2014US20140256663 Amphotericin Analogous Compounds and Pharmaceutical Compositions Containing Them
09/11/2014US20140256647 Kits and methods for the treatment of cancer using gliadin peptides
09/11/2014US20140256642 Treatment of degenerative joint disease
09/11/2014US20140256632 Methods useful in the treatment of bone resorption diseases
09/11/2014US20140256619 Use of avermectin derivative for increasing bioavailability and efficacy of macrocylic lactones
09/11/2014US20140256613 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
09/11/2014US20140255524 Alpha-gpc dietary supplements for weight loss and/or increasing or maintaining lean body mass
09/11/2014US20140255522 Topical compositions and methods of treatment of anorectal and genital disorders
09/11/2014US20140255521 Topical compositions and methods of treatment of topical disorders
09/11/2014US20140255518 Treatment and Prevention of Gastrointestinal Syndrome
09/11/2014US20140255517 Managing post-traumatic stress disorder
09/11/2014US20140255513 Lytic domain fusion constructs and methods of making and using same
09/11/2014US20140255512 Composition useful for the prevention or reduction of the progression of prostate cancer
09/11/2014US20140255509 Composition
09/11/2014US20140255497 Organic Compounds
09/11/2014US20140255485 Collagen hydrolysate and use thereof
09/11/2014US20140255462 Xenotransplant Compositions and Methods of Stroke Therapy
09/11/2014US20140255454 Methods of wound care and treatment
09/11/2014US20140255453 Herbal ointment for musculoskeletal and joint-related conditions
09/11/2014US20140255433 Pde5 inhibitor compositions and methods for immunotherapy
09/11/2014US20140255432 Silvestrol, silvestrol analogs and uses thereof
09/11/2014US20140255429 Methods of Treating Autoimmune Diseases with DLL4 Antagonists
09/11/2014US20140255428 Quinazoline Inhibitors of activating mutant forms of Epidermal Growth Factor Receptor
09/11/2014US20140255426 Wnt pathway inhibitors for treating viral infections
09/11/2014US20140255413 Combination therapy for neoplasia treatment
09/11/2014US20140255410 Specific binding proteins and uses thereof
09/11/2014US20140255408 Bispecific EGFR/C-Met Antibodies
09/11/2014US20140255404 Pulmonary hypertension
09/11/2014US20140255394 Method of Treating Colorectal Cancer
09/11/2014US20140255392 Substituted imidazopyridines and intermediates thereof
09/11/2014US20140255391 Methods for the treatment of il-1beta related diseases
09/11/2014US20140255390 Method of Treating Rheumatoid Arthritis With An Anti-IL-6R Antibody
09/11/2014US20140255389 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
09/11/2014US20140255386 Microrna modulators and method for identifying and using the same
09/11/2014US20140255382 Solid composition containing a hypothiocyanite salt
09/11/2014US20140255372 Co-enzyme q10 formulations and methods of use
09/11/2014US20140255371 Physical Optimization Beverage
09/11/2014US20140255363 Targeting the tumor microenvironment using manipulated nkt cells
09/11/2014US20140255350 Composition And Methods For Inhibiting Pathogenic Growth
09/11/2014US20140255348 Cancer therapy using a combination of hsp90 inhibitors with topoisomerase i inhibitors
09/11/2014US20140255347 Macrocyclic Inhibitors Of Hepatitis C Virus
09/11/2014US20140255344 Antiviral Compounds
09/11/2014US20140255342 Thiophene derivatives
09/11/2014US20140255341 Tumor Selective Chemokine Modulation
09/11/2014US20140255340 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
09/11/2014US20140255299 Methods and Compositions Comprising a C-Terminal Bax Peptide
09/11/2014DE102013004454A1 Mittel zur Sensibilisierung solider, maligner Tumore gegenüber Chemotherapeutika und Strahlentherapie Means of raising awareness of solid, malignant tumors to chemotherapy and radiotherapy
09/10/2014EP2774623A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
09/10/2014EP2774622A1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 1151